Immunological Medicines for Poultry
Immunological veterinary medicinal products, including vaccines, are authorised for poultry.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
Dindoral SPF
|
Infektiöse Hämorrhagische Enteritis
|
Boehringer Ingelheim Vetmedica GmbH
|
5a/95 |
22.07.1996 |
Pute |
PharmNet.Bund
|
Terivac
|
Infektiöse Rhinotracheitis
|
Boehringer Ingelheim Vetmedica GmbH
|
106a/90 |
18.11.1998 |
Pute |
PharmNet.Bund
|
Trituren
|
Newcastle Disease,
Paramyxovirose der Pute,
Infektiöse Rhinotracheitis
|
Boehringer Ingelheim Vetmedica GmbH
|
38a/92 |
27.12.1994 |
Pute |
PharmNet.Bund
|
Poulvac TRT
|
Infektiöse Rhinotracheitis
|
Zoetis Deutschland GmbH
|
PEI.V.01721.01.1 |
05.12.2000 |
Pute |
PharmNet.Bund
|
Chevivac-P12
|
Paramyxovirose der Taube
|
chevita Tierarzneimittel GmbH
|
235a/97 |
19.06.1998 |
Taube |
PharmNet.Bund
|
Pharmavac PHA
|
Paramyxovirose der Taube, Infektion mit Tauben-Herpesvirus, Infektion mit Aviärem Adenovirus
|
Pharmagal Bio, spol.s.r.o., Slowakei
|
PEI.V.11963.01.1 |
15.10.2018 |
Taube |
PharmNet.Bund
|
Chevivac PMV
|
Paramyxovirose der Taube
|
chevita Tierarzneimittel GmbH
|
PEI.V.11653.01.1 |
04.10.2012 |
Taube |
PharmNet.Bund
|
Chevivac-S
|
Salmonellen-Infektion
|
chevita Tierarzneimittel GmbH
|
PEI.V.00272.01.1 |
18.05.1998 |
Taube |
PharmNet.Bund
|
Nobilis Paramyxo P201
|
Paramyxovirose der Taube
|
Intervet Deutschland GmbH
|
243a/97 |
28.03.2000 |
Taube |
PharmNet.Bund
|
Chevipok
|
Taubenpocken
|
chevita Tierarzneimittel GmbH
|
PEI.V.11530.01.1 |
24.06.2011 |
Taube |
PharmNet.Bund
|
RP Vacc
|
Paramyxovirose der Taube, Rotavirus-Infektion der Taube
|
Pharmagal Bio, spol.s.r.o., Slowakei
|
PEI.V.12101.01.1 |
06.12.2021 |
Taube |
PharmNet.Bund
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 530 in BAnz AT 16.06.2025 B4.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.